| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Mycobacterium tuberculosis (clinical 900216 + pH 6.8) |
- |
- |
40 － ? |
HMR 3004 (RU 64004)  |
61 |
| Mycobacterium tuberculosis (clinical isolate + multidrug-resistant) |
- |
- |
<0.008 － 0.06 |
Gatifloxacin (Tequin) |
620 |
| Mycobacterium tuberculosis (clinical isolate + multidrug-resistant) |
- |
- |
0.06 － 1 |
PDF-611(LBK-611) |
620 |
| Mycobacterium tuberculosis (clinical isolate + multidrug-resistant) |
- |
- |
0.06 － 2 |
BB-3497 |
620 |
| Mycobacterium tuberculosis (clinical isolate + pH 6.0) |
0.5 |
- |
? － ? |
WIN 57273 |
994 |
| Mycobacterium tuberculosis (clinical isolate + pH 6.0) |
1 |
- |
? － ? |
Ofloxacin (Floxin) |
994 |
| Mycobacterium tuberculosis (clinical isolate + pH 6.0) |
2 |
- |
? － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
994 |
| Mycobacterium tuberculosis (clinical isolate + pH 6.8) |
1 |
- |
? － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
994 |
| Mycobacterium tuberculosis (clinical isolate + pH 6.8) |
1 |
- |
? － ? |
Ofloxacin (Floxin) |
994 |
| Mycobacterium tuberculosis (clinical isolate + pH 6.8) |
2 |
- |
? － ? |
WIN 57273 |
994 |
| Mycobacterium tuberculosis (clinical isolate 900145 + pH 6.8) |
- |
- |
20 － ? |
Clarithromycin (Biaxin) |
61 |
| Mycobacterium tuberculosis (clinical isolate 900145 + pH 6.8) |
- |
- |
40 － ? |
HMR 3004 (RU 64004) |
61 |
| Mycobacterium tuberculosis (clinical isolate 900145 + pH 6.8) |
- |
- |
40 － ? |
HMR 3004 (RU 64004) |
61 |
| Mycobacterium tuberculosis (clinical isolate 900145 + pH 6.8) |
- |
- |
>40 － ? |
Telithromycin (HMR 3647, RU-66647, Ketek) |
61 |
| Mycobacterium tuberculosis (clinical isolate 900145 + pH 7.4) |
- |
- |
5 － ? |
Clarithromycin (Biaxin) |
61 |
| Mycobacterium tuberculosis (clinical isolate 900145 + pH 7.4) |
- |
- |
10 － ? |
HMR 3004 (RU 64004) |
61 |
| Mycobacterium tuberculosis (clinical isolate 900145 + pH 7.4) |
- |
- |
10 － ? |
HMR 3004 (RU 64004) |
61 |
| Mycobacterium tuberculosis (clinical isolate 900145 + pH 7.4) |
- |
- |
>40 － ? |
Telithromycin (HMR 3647, RU-66647, Ketek) |
61 |
| Mycobacterium tuberculosis (clinical isolate 900216 + pH 6.8) |
- |
- |
20 － ? |
Clarithromycin (Biaxin) |
61 |
| Mycobacterium tuberculosis (clinical isolate 900216 + pH 6.8) |
- |
- |
40 － ? |
HMR 3004 (RU 64004) |
61 |
| Mycobacterium tuberculosis (clinical isolate 900216 + pH 6.8) |
- |
- |
40 － ? |
HMR 3004 (RU 64004) |
61 |
| Mycobacterium tuberculosis (clinical isolate 900216 + pH 6.8) |
- |
- |
>40 － ? |
Telithromycin (HMR 3647, RU-66647, Ketek) |
61 |
| Mycobacterium tuberculosis (clinical isolate 900216 + pH 7.4) |
- |
- |
5 － ? |
Clarithromycin (Biaxin) |
61 |
| Mycobacterium tuberculosis (clinical isolate 900216 + pH 7.4) |
- |
- |
10 － ? |
HMR 3004 (RU 64004) |
61 |
| Mycobacterium tuberculosis (clinical isolate 900216 + pH 7.4) |
- |
- |
10 － ? |
HMR 3004 (RU 64004) |
61 |
| Mycobacterium tuberculosis (clinical isolate 900216 + pH 7.4) |
- |
- |
>40 － ? |
Telithromycin (HMR 3647, RU-66647, Ketek) |
61 |
| Mycobacterium tuberculosis (clinical isolate) |
- |
- |
64 － ? |
D-ofloxacin |
994 |
| Mycobacterium tuberculosis (clinical isolate-susceptible) |
0.06 |
- |
0.03 － 0.12 |
R207910 (TMC207) |
1442 |